POMPANO BEACH, Fla., July 6, 2007 (PRIME NEWSWIRE) -- MEDirect Latino Inc. (Pink Sheets:MLTO), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced the appointment of a new member of the board.
The board nominated and approved Mr. Henry R. Autry as a director to fill the board vacancy created by Mr. Ruben King-Shaw's resignation as Chairman on June 25, 2007. Mr. Autry is the CEO of Contrado Partners, a global consulting firm based in Chicago. He previously served as CEO of Brigade Solutions; Senior Vice President and General Manager of World Wide Travelers Cheque Group of American Express Company; President and COO of Release International; Senior Vice President and Chief Administrative Officer of Baxter International with global responsibility for manufacturing, logistics, and IT; and Head of Worldwide Sales at FedEx. Mr. Autry is an experienced public director having most recently served on the board of Hyperion Solutions (Nasdaq:HYSL) from 2000 until 2007 when the company was acquired by Oracle Corp. for $2.4 billion. Additionally, Mr. Autry serves on the board of Trinity Healthcare, a $6 billion hospital system.
In announcing the changes at MEDirect Latino, Interim-CEO Charles Hansen stated, "On behalf of MEDirect Latino, I would like to welcome Henry Autry to our board. We are fortunate in knowing that Henry will be a great addition to the team."
ABOUT MEDIRECT LATINO:
MEDirect Latino, Inc. (www.medirectlatino.org) is the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community. MEDirect Latino is rapidly growing and uniquely positioned to service the Hispanic community in the United States and Puerto Rico. MEDirect is the only company currently positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. Type II diabetes was targeted because of its unique status within the Medicare reimbursement regime and due to its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These and other conditions represent considerable future market potential, MEDirect will scale its model by leveraging its existing client base and infrastructure in introducing new products and services to existing customers as they are identified.
The MEDirect Latino Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=1873
Safe Harbor Disclosure: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.